â??A Clinical Study on Swarnaprashan to Establish its Safety in children suffering from recurrent infections"

â??An Experimental and Clinical Study on Swarnaprashan to Establish its Safety, antimicrobial activity and to Assess its Immunogenicity Effect after BCG Vaccinationâ??

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036941

Enrollment

Registered

2021-09-29

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J06- Acute upper respiratory infectionsof multiple and unspecified sites

Interventions

Intervention1: â??An Experimental and Clinical Study on Swarnaprashan to Establish its Safety, antimicrobial activity and to Assess its Immunogenicity Effect after BCG Vaccinationâ??: It will be a sin

S.S. Hospital, IMS, BHU after assessing the following exclusion and inclusion criteria - Intervention2: An Experimental and Clinical Study on Swarnaprashan to Establish its Safety, antimicrobial acti

S.S. Hospital, IMS, BHU after assessing the following exclusion and inclusion criteria - dURATION OF STUDY -3 MONTHS Control Intervention1: SWARNAPRASHAN: After confirming the non-toxic effects of Sw

Eligibility

Inclusion criteria

Inclusion criteria: a) Age between 1to 15 years b) Having history of repeated respiratory or any other recurrent disorder irrespective to associated congenital, hereditary or developmental/nutritional disorders c) Period of drug administration - asymptomatic Phase

Exclusion criteria

Exclusion criteria: a) Neonates and infants b) During any symptomatic illness c) Suffering from degenerative neurological, IEM, etc.

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN immunity and overall health condition due to reduction in number of episodes of illness and safety of drugTimepoint: after one month of administration of drug	—

Secondary

Measure	Time frame
IMPROVEMENT IN immunity and overall health condition due to reduction in number of episodes of illnessTimepoint: after 2months of follow up	—

Countries

India

Contacts

Public ContactDR SAHANA SHANKARI

INSTITUTE OF MEDICAL SCIENCE BHU VARANASI

hodkb2006@yahoo.in7355644462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026